Adverts

Open Access Articles- Top Results for YM-31636

YM-31636

YM-31636
200px
colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other
This page is a soft redirect. Names

#REDIRECTmw:Help:Magic words#Other
This page is a soft redirect.-

IUPAC name
2-(1H-imidazol-4-ylmethyl)-8H-indeno[1,2-d]thiazole
colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other
This page is a soft redirect. Properties

#REDIRECTmw:Help:Magic words#Other
This page is a soft redirect.-

C14H11N3S
Molar mass 253.32 g mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

YM-31636 is a potent and selective 5-HT3 agonist.[1] Systemic administration of YM-31636 increased the number of fecal pellets in rats, and improves colonic motility. It also increases colonic secretions, but not to the point of inducing diarrhea. In addition, it did not reduce the visceral pain threshold, or increase the intensity of visceral pain.[2] These properties indicate that it could be a useful treatment for constipation.

References

  1. ^ Ito, H. (December 2000). "Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.". European Journal of Pharmacology 409 (2): 195–201. PMID 11104834. doi:10.1016/S0014-2999(00)00851-7. 
  2. ^ Kiso, T. (November 2001). "A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing abdominal pain.". European Journal of Pharmacology 431 (1): 35–41. PMID 11716840. doi:10.1016/S0014-2999(01)01425-X.